For medical device OEMs moving from development to commercialization, the path from approved design to reliable production is rarely simple. Documentation must be complete. Processes must be validated. Suppliers must be qualified. Production teams must understand how the device is built, inspected, tested, packaged, and controlled.
One of the most common sources of confusion is the difference between design transfer and manufacturing transfer.
Both are critical to medical device commercialization and lifecycle management. Both involve moving technical information, processes, and responsibilities from one stage or site to another. But they are not the same process, and treating them as interchangeable can create serious delays, quality issues, regulatory risk, and unnecessary cost.
For OEMs working with a medical device contract manufacturer, understanding the difference can help protect production timelines, improve quality outcomes, and reduce risk during commercialization or product relocation.
Design transfer translates a verified and validated medical device design into controlled production specifications before commercialization. Manufacturing transfer moves an already-released product from one production site or contract manufacturer to another while maintaining equivalent quality, performance, and process control.
Design transfer is the formal process of translating a verified and validated medical device design into production specifications that can be consistently manufactured. It is part of the broader quality system expectations outlined in the FDA Quality System Regulation, which governs the methods, facilities, and controls used in medical device manufacturing.
In practical terms, design transfer moves the product from engineering and development into a controlled manufacturing environment. The goal is to ensure that what was designed, tested, and approved can be reliably built at scale.
A successful design transfer typically includes:
The key question in design transfer is:
Can the approved design be manufactured repeatedly, consistently, and in compliance with quality and regulatory requirements?
That question matters because a prototype that works in development may not be ready for repeatable production. Missing tolerances, unclear assembly steps, incomplete inspection requirements, unvalidated processes, or weak supplier documentation can all create problems once production begins.
For medical device OEMs, design transfer is a controlled, cross-functional process that connects engineering, quality, regulatory, supply chain, and manufacturing.
Poor design transfer creates problems that often appear late in the commercialization process, when they are more expensive and more disruptive to fix.
Common issues include:
For OEMs under pressure to launch, it can be tempting to move quickly from development to production. But a successful new product introduction for medical devices requires the manufacturing partner to have complete, controlled, and buildable documentation. Otherwise, the production floor becomes the place where design gaps are discovered.
That is the wrong place to find them.
A strong design transfer process helps confirm that the device is not only technically sound, but also manufacturable, inspectable, testable, and scalable.
Manufacturing transfer is different. It occurs when an already-released medical device is moved from one production environment to another.
Medical device production line transfer happens when an OEM moves production:
In a manufacturing transfer, the product design is already released. The challenge is to replicate the existing manufacturing system at a new site while maintaining quality, performance, documentation, and process control.
That means the transfer must account for more than the device drawing or BOM. It must evaluate the full production ecosystem, including:
The key question in manufacturing transfer is:
Can the new site reproduce the same device with equivalent quality, performance, and process control?
Manufacturing transfer often appears straightforward on paper. If the device is already in production and the documentation exists, it may seem like another qualified facility should be able to reproduce the same result.
In practice, subtle differences can create meaningful variation.
A new production site may use different equipment, fixtures, operators, suppliers, inspection tools, environmental conditions, calibration practices, or process controls. Even when the BOM and drawings remain unchanged, those differences can affect quality, yield, performance, and compliance.
Common manufacturing transfer risks include:
For regulated medical devices, manufacturing transfer should be managed through a formal transfer protocol, gap analysis, validation plan, and quality review. The objective is not simply to “move production.” The objective is to prove that the new manufacturing environment can produce the device consistently and compliantly.
Planning a Medical Device Transfer?
Sanbor Medical can help assess your transfer readiness, identify documentation or validation gaps, and support a smoother path to controlled production.
Discuss Your Transfer Project
| Category | Design Transfer | Manufacturing Transfer |
|---|---|---|
| When it happens | Before commercial production begins | After the product is already released or in production |
| Primary purpose | Translate the approved design into controlled production | Move existing production to a new site or partner |
| Primary input | Verified and validated design outputs | Released product, production records, and existing manufacturing process |
| Primary output | Production-ready documentation and validated manufacturing process | Equivalent production capability at the new site |
| Main risk | Design intent is not fully translated into production controls | Existing production process is not accurately replicated |
| Common issues | Missing specifications, unclear work instructions, incomplete validation | Process drift, supplier gaps, equipment differences, validation failures |
| OEM priority | Commercialization readiness | Continuity, equivalency, quality, and supply stability |
Design transfer and manufacturing transfer are connected across the medical device lifecycle.
A strong design transfer makes the initial production launch smoother. It also makes future manufacturing transfers easier because the product history, production documentation, supplier requirements, and validation records are already complete and controlled.
A weak design transfer has the opposite effect. If the original production documentation is incomplete, ambiguous, or not aligned with actual manufacturing practice, any future transfer becomes much more difficult. The new manufacturing partner may be forced to reconstruct the process from tribal knowledge, outdated drawings, incomplete work instructions, or inconsistent records.
That creates risk.
For OEMs, this is especially important when planning for scale, supplier diversification, geographic manufacturing flexibility, or contract manufacturer transitions. The stronger the documentation and process controls are from the start, the easier it is to maintain product continuity as the business evolves.
Design transfer should begin before production launch pressure reaches its peak. OEMs should involve manufacturing, quality, regulatory, and supply chain teams early enough to identify gaps before they become production problems.
Pilot builds, first article inspection, operator feedback, and process validation planning should be built into the timeline.
Work instructions, inspection criteria, validation records, and supplier documentation should be written so another qualified manufacturing site can understand and reproduce the process later.
Clear documentation supports commercialization today and protects transfer flexibility in the future.
A successful prototype or engineering build does not prove that a process is ready for repeatable production. OEMs should confirm that the manufacturing process can consistently produce conforming product under defined conditions.
For many medical devices, that means aligning production readiness with appropriate process validation, inspection, testing, and quality control requirements.
Before moving production to a new facility, OEMs should compare the current manufacturing system against the proposed new site.
That review should include equipment, tooling, supplier availability, operator skill requirements, inspection methods, environmental controls, packaging, labeling, validation requirements, and quality system alignment.
Manufacturing site changes, process changes, supplier changes, or validation changes may have regulatory implications depending on the device, market, and change type.
OEMs should evaluate those implications early so the transfer plan, documentation strategy, and regulatory pathway remain aligned.
Medical device transfers require more than manufacturing capacity. They require disciplined documentation, quality system alignment, validation support, supplier control, and an understanding of regulated production environments.
The right contract manufacturing partner can help OEMs identify risks early, close documentation gaps, support validation planning, and establish a controlled path from design intent to repeatable production.
Sanbor Medical helps medical device OEMs move from development to production and from one manufacturing environment to another with a disciplined, quality-focused approach.
Our team supports OEMs through critical transfer activities, including documentation review, manufacturing readiness assessment, supplier coordination, production planning, first article builds, process validation support, and controlled ramp-up.
For OEMs approaching commercialization, Sanbor Medical helps translate approved designs into scalable production processes.
For OEMs moving an existing product from another facility or contract manufacturer, Sanbor Medical helps evaluate the current manufacturing process, identify transfer risks, and establish a controlled plan for continuity, quality, and compliance.
Whether the goal is commercialization, cost improvement, production scale-up, supply chain diversification, or a new contract manufacturing partnership, the transfer process must be handled with discipline.
Design transfer and manufacturing transfer are not interchangeable.
Design transfer helps ensure that an approved medical device design can be manufactured consistently. Manufacturing transfer helps ensure that an existing production process can be moved to a new site without compromising quality, performance, or compliance.
For medical device OEMs, both processes are essential. Done well, they support smoother commercialization, stronger production control, better supplier flexibility, and reduced lifecycle risk. Done poorly, they can create delays, quality problems, rework, and regulatory exposure.
If your team is preparing for design transfer, manufacturing transfer, or a contract manufacturing transition, Sanbor Medical can help you evaluate the path forward and establish a controlled, production-ready plan.
Contact Sanbor Medical to discuss your medical device transfer needs.
Design transfer is the process of translating a verified and validated medical device design into controlled production specifications, work instructions, inspection criteria, test methods, and validated manufacturing processes.
Manufacturing transfer is the process of moving production of an already-released medical device from one facility, production line, or contract manufacturer to another while maintaining equivalent quality, performance, and process control.
Design transfer happens before commercial production begins and focuses on moving the design into production. Manufacturing transfer happens after the product is already released and focuses on moving an existing production process to a new site or partner.
Design transfer helps ensure the approved device design can be built consistently, inspected properly, tested accurately, and manufactured under controlled quality system requirements.
Manufacturing transfer can create risk because equipment, tooling, suppliers, operator training, environmental conditions, and process controls may differ between production sites. Those differences can affect quality, performance, validation, and compliance.